Sustainability Report 2017
Orion's Sustainability Report for 2017 was published on 4 May 2018.
Orion has reported on its sustainability since 2009, the report for 2017 is our 9th sustainability report.
Our reporting comprises all business divisions of the Orion Group, except for environmental data, which is only collected for our Finnish locations.
The Report starts with a Company Profile, which includes President and CEO Timo Lappalainen’s statement on our corporate responsibility.
Each thematic section starts with a description of our Management Approach, featuring how that particular area of corporate responsibility is managed in our Group. The Approaches are also provided on separate web pages, here.
Indicators demonstrate our progress and performance in the review year and the two previous ones. Key factors affecting the development are reported.
The Tables section in the end of the Report gives a summary of the figures reported.
Sustainability at Orion means balancing social, economical and environmental factors and is a principle built into our common values. The report addresses essential sustainability aspects based on materiality. For a pharmaceutical company, it is important to manage, and continuously improve, sustainability while also ensuring patient safety and high quality throughout the product life cycle – from research and development through to manufacturing to patient use and product end-of-life disposal.
This year, in addition to information about our own operations, our sustainability report also contains information about how we are addressing general concerns in society. We tell about our efforts in solving the global problem of antimicrobial resistance, here. We also tell about how we consider sustainability aspects during the entire lifecycle of a pharmaceutical product, here.
Patient safety is the guiding value in all Orion's operations and in essence of corporate responsibility. This responsibility involves a lot to care for and make sure of: the Good Practices (GxP) requirements must be met without compromise throughout our supply chain, including our suppliers. A medicinal product must fulfil the registered specifications confirmed for it. Departures from the standards shall not proceed to the market.
The section dealing with Product Responsibility is on pages 12-22 of the Report.
Our aim is to keep the best possible control of the environmental impacts of our operations by applying the principles and practices determined in our EHS Management System. The System comprises our approaches to environmental affairs, energy efficiency, occupational health and occupational and process safety. The carrying principle is continuous improvement.
In 2017, we have made progress especially on energy and waste water management. We are committed to reaching the energy savings target for 2025, which is 7.5% of energy consumption in 2016. This means a saving of slightly over 12 GWh, 31% of which was achieved in 2017. In energy section, especially Espoo site energy savings projects (3,725 MWh savings) are highlighted (page 35)
In 2017, we have made significant progress also on waste water management and the reduction of pharmaceutical residue emissions. We had set ourselves ambitious targets a few years ago and last year we finished the project aimed at decreasing the environmental burden on waterways even further, even though of course we had already fulfilled the legal requirements before. We have improved waste water management and got the new pre-rinse water collection systems running at our production sites. Most of the active pharmaceutical ingredients containing waste water are now being collected and sent to treatment with a 100% reduction. In water and effluents section is a summary of the successful waste water project (page 39).
The section dealing with Environmental Responsibility is on pages 23–40 of the Report.
This part of the Sustainability Report describes our Group as a working community and our principles and practices as builders of well-being. As defined in our Group strategy, we make success together by doing valuable and meaningful work for our customers, by showing responsibility as an employer, by being an excellent workplace and an attractive employer, and by continuously developing our employees’ occupational well-being and competence.
In 2017, our emphasis in particular has been focusing on the occupational health and safety of Orionees. The work done to prevent accidents and injuries at Orion facilities is leading to positive results. During the course of the year, a Group-wide occupational safety network was set up, and we have been working on several programmes aimed especially at enhancing Group’s safety culture. It is not sufficient simply to safeguard oneself; instead employees are encouraged to require this from their colleagues too. We want to promote a culture where Orionees intervene if they observe unsafe work practices and where it is everyone's duty to do so. Intervening is an act of caring, and we believe that this cultural change will assist us in our journey to zero accidents.
Our focus on occupational safety and the ongoing and completed actions to improve it (page 46-47), in indicators more emphasis on the causes and results of actions (page 51-52).
A short characterisation of our employee structure is provided on pages 53–54 of the Report. Information about the structure of our personnel is provided in the Tables section.
The section dealing with Labour Practices is on pages 41–54 of the Report.
• Product Responsibility • Environmental Responsibility • Labour Practices and Decent Work • Economic Responsibility • Human Rights • Society
Statement by CEO Timo Lappalainen in our Sustainability Report for 2017